Breast cancers that do not express the estrogen receptor (ER) and the progesterone receptor (PR) and that do not overexpress human epidermal growth factor receptor 2 (HER2) are collectively grouped as triple-negative breast cancer (TNBC). Here, ESR1 is linked to breast cancer.